Company profile
TECregen AG
TECregen is dedicated to advancing immuno-rejuvenation by developing next generation therapies to regenerate the thymus.
- Industry
- Biotechnology Research
- Employees
- 14
- Headquarters
- Basel
- Office locations
- 1
TECregen AG company summary
TECregen AG is a company in the Biotechnology Research industry, headquartered in Basel. On LinkedIn the company has around 14 employees.
What technology does TECregen AG use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About TECregen AG
TECregen is pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses. The company’s innovative approach focuses on revitalizing and expanding thymic epithelial cells (TECs) to replenish T cells and achieve durable improvements in immune function. By developing a pipeline of differentiated thymopoietic biologics, TECregen aims to strengthen immune recovery following transplantation or cytotoxic therapy, promote immune health, and enhance immune surveillance against cancer, ushering in a new era of immunotherapy.
Where is TECregen AG located?
TECregen AG lists 1 location.
Compare companies similar to TECregen AG
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
TECregen AG tecregen.com | Biotechnology Research | 14 | - | Basel |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about TECregen AG
What does TECregen AG do?
TECregen is pioneering thymus rejuvenation to address conditions driven by impaired T-cell responses. The company’s innovative approach focuses on revitalizing and expanding thymic epithelial cells (TECs) to replenish T cells and achieve durable improvements in immune function. By developing a pipeline of differentiated thymopoietic biologics, TECregen aims to strengthen immune recovery following transplantation or cytotoxic therapy, promote immune health, and enhance immune surveillance against cancer, ushering in a new era of immunotherapy.
How many employees does TECregen AG have?
TECregen AG has around 14 employees on LinkedIn.
Where is TECregen AG headquartered?
TECregen AG is headquartered in Basel.
Build a lead list from companies like TECregen AG
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.